Journal
ONCOGENE
Volume 27, Issue 44, Pages 5785-5796Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/onc.2008.192
Keywords
transcription; p53; hypoxia-inducible factor; PCAF; apoptosis
Funding
- School of Pharmacy, University of Manchester
- Cancer Research UK
- MRC programme [G0500366]
- Wellcome Trust [069024]
- MRC [G0500366] Funding Source: UKRI
- Medical Research Council [G0500366] Funding Source: researchfish
Ask authors/readers for more resources
The p53 tumour suppressor is involved in several crucial cellular functions including cell-cycle arrest and apoptosis. p53 stabilization occurs under hypoxic and DNA damage conditions. However, only in the latter scenario is stabilized p53 capable of inducing the expression of its pro-apoptotic targets. Here we present evidence that under hypoxia-mimicking conditions p53 acetylation is reduced to a greater extent at K320 site targeted by P300/CBP-associated factor (PCAF) than at K382 site targeted by p300/CBP. The limited amounts of acetylated p53 at K320 are preferentially recruited to the promoter of the p21(WAF-1/CIP-1) gene, which appears to be unaffected by hypoxia, but are not recruited to the BID promoter and hence p53 is incapable of upregulating pro-apoptotic BID in hypoxic conditions. As the K320 p53 acetylation is the site predominantly affected in hypoxia, the PCAF histone acetyltransferase activity is the key regulator of the cellular fate modulated by p53 under these conditions. In addition, we provide evidence that PCAF acetylates hypoxia-inducible factor-1 alpha (HIF-1 alpha) in hypoxic conditions and that the acetylated HIF-1 alpha is recruited to a particular subset of its targets. In conclusion, PCAF regulates the balance between cell-cycle arrest and apoptosis in hypoxia by modulating the activity and protein stability of both p53 and HIF-alpha.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available